Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-07-25
2006-07-25
Owens, Amelia A. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S313000, C514S338000, C514S357000, C514S252030, C544S235000, C546S159000, C546S283100, C546S275700, C546S330000, C546S337000
Reexamination Certificate
active
07081468
ABSTRACT:
Ortho-substituted anthranilic acid amides and use thereof as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described.
REFERENCES:
patent: 6448277 (2002-09-01), Altmann et al.
patent: WO 0027819 (2000-05-01), None
patent: WO 0027820 (2000-05-01), None
Strandtmann et al, J. Med. Chem. (1967), 10(6):1063-1065.
Sofina et al. Experimental Evaluation of Antitumor Drugs in the USA and USSR and Clinical Correlations. NCI Monograph 55. NIH Publication No. 80-1933 (1980).
Augustin, “Antiangiogenic tumour therapy: will it work?”Trends in Pharmacological Sciences, Elsevier Trends Journal, vol. 19, No. 6, Jun. 1, 1998, pp. 216-222, XP004145666.
Ernst Alexander
Haberey Martin
Huth Andreas
Krueger Martin
Menrad Andreas
Millen White Zelano & Branigan P.C.
Owens Amelia A.
Schering AG
LandOfFree
Ortho-substituted anthranilic acid amides and their use as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ortho-substituted anthranilic acid amides and their use as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ortho-substituted anthranilic acid amides and their use as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3567560